Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedation with remimazolam vs dexmedetomidine for extraction of third molars
KCT0009615Phase 4Recruiting
- Sponsor
- National Research Foundation
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of remimazolam, dexmedetomidine in impacted tooth, sponsored by National Research Foundation. Started Nov 2022; status: recruiting.
02
Drugs
remimazolamdexmedetomidine
03
Conditions
impacted tooth
Beyond the preview
Go deeper on KCT0009615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009615.